A 70 year old male known case of a ceain malignancy presents with elevated erythropoietin levels and PCV of 52%. Most likely tumour is
**Core Concept**
The question is testing the association between elevated erythropoietin (EPO) levels, polycythemia (elevated hematocrit/PCV), and a specific type of malignancy. Erythropoietin is a hormone produced by the kidneys that stimulates red blood cell production. In certain cancers, EPO levels can become elevated, leading to increased red blood cell production and resulting in polycythemia.
**Why the Correct Answer is Right**
In this scenario, the elevated EPO levels are likely due to the production of EPO by the tumor itself. This is known as tumor erythropoietin syndrome (TES). The most common malignancy associated with TES is renal cell carcinoma (RCC), particularly the clear cell subtype. Other options may also produce EPO, but RCC is the most commonly associated tumor. The pathophysiology involves the tumor cells producing EPO, which leads to increased red blood cell production, resulting in polycythemia.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because while other cancers can produce EPO, they are less commonly associated with TES compared to RCC.
**Option B:** This option is incorrect because while liver diseases can cause polycythemia, they are not typically associated with elevated EPO levels due to tumor production.
**Option C:** This option is incorrect because while certain infections can cause polycythemia, they are not typically associated with elevated EPO levels due to tumor production.
**Clinical Pearl / High-Yield Fact**
When encountering a patient with elevated EPO levels and polycythemia, consider the possibility of tumor erythropoietin syndrome (TES) and perform a thorough evaluation for underlying malignancy, particularly renal cell carcinoma.
**Correct Answer:** A. Renal cell carcinoma.